[Long-term survival achieved with benmelstobart plus anlotinib in a patient with advanced clear cell renal cell carcinoma: A case report].
- DOI
- 10.19723/j.issn.1671-167x.2026.04.026
- Published
- 2026 Aug 18
- Container
- Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.19723/j.issn.1671-167x.2026.04.026,
title = {[Long-term survival achieved with benmelstobart plus anlotinib in a patient with advanced clear cell renal cell carcinoma: A case report].},
author = {Tian H and Zhang J and Li J},
year = {2026},
journal = {Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences},
doi = {10.19723/j.issn.1671-167x.2026.04.026},
url = {https://doi.org/10.19723/j.issn.1671-167x.2026.04.026}
}RIS
TY - JOUR TI - [Long-term survival achieved with benmelstobart plus anlotinib in a patient with advanced clear cell renal cell carcinoma: A case report]. AU - Tian H AU - Zhang J AU - Li J PY - 2026 JO - Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences DO - 10.19723/j.issn.1671-167x.2026.04.026 UR - https://doi.org/10.19723/j.issn.1671-167x.2026.04.026 ER -
APA
H, T., J, Z., & J, L. (2026). [Long-term survival achieved with benmelstobart plus anlotinib in a patient with advanced clear cell renal cell carcinoma: A case report].. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences. https://doi.org/10.19723/j.issn.1671-167x.2026.04.026
Source records
- pubmed · retrieved 2026-09-27T12:01:31.345Z